Applications published 3 August 2011
Selected patent applications from the weekly European Patents Bulletin
- Selective proton coupled folate transporter and folate receptor, and garftase inhibitor compounds and methods of using the same
Duquesne University of the Holy Ghost; Wayne State University 2348843*
- Cross-linked fatty acid-based biomaterials
Atrium Medical 2348844*
- Ansamycin hydroquinone compsns
Infinity Pharmaceuticals 2348845*
- Disubstituted azepan orexin receptor antagonists
Merck Sharp & Dohme 2348846*
- Azepino [4,5-B] indoles and methods of use
Medivation Technologies 2348847*
- Treatment of hepatitis C infection with metalloporphyrins
Charlotte-Mecklenburg Hospital Authority doing business as Carolinas Medical Centre 2348848*
- High solid dispersions comprising biocides
Janssen Pharmaceutica 2348853*
- Methods and compsns for treating bacterial infections by inhibiting quorum sensing
Albert Einstein College of Medicine of Yeshiva University 2348854*
- Small molecule compounds for stem cell differentiation
Burnham Institute of Medical Research 2348855*
- 2,4-disubstituted pyrrolidine orexin receptor antagonists
Merck Sharp & Dohme 2348856*
- Novel cyclic benzimidazole derivatives useful as anti-diabetic agents
Merck Sharp & Dohme; Metabasis Therapeutics 2348857*
- Method of treating thrombocytopenia
GlaxoSmithKline 2348858*
- Prodrugs of oxazolidinone CETP inhibitors
Merck Sharp & Dohme 2348859*
- Pyrazolopyrimidine JAK inhibitor compounds and methods
Genentech 2348860*
- Pesticidal compsn comprising an alpha-alkoxyphenyl acetic acid derivative and a neonicotinoid compound
Sumitomo Chemical 2348861*
- Boron-containing small molecules
Anacor Pharmaceuticals 2348863*
- Oxidised thiophospholipid compounds and uses thereof
Vascular Biogenics 2348864*
- Beta-hydroxy-gamma-aminophosphonates and methods for the preparation and use thereof
Nuctiec 2348865*
- Oxidised lipid compounds and uses thereof
Vascular Biogenics 2348866*
- Niovel mitochondrial uncoupling methods and compsns for enhancing adipocyte thermogenesis
Metaproteomics 2348868*
- Aqueous saline solutions for the destruction of fatty tissue
Lipolyane 2349188*
- Pharmaceutical compsn for the treatment of periodontal diseases
Akademia Medyczna Im Piastow Slaskich We Wroclawiu 2349199*
- Highly concentrated drug particles, formulations, suspensions and uses thereof
Intarcia Therapeutics 2349200*
- Formulation of treatment for vaginal dryness
Medlite 2349201*
- Drug delivery systems and methods for treating neovascularisation
Allergan 2349202*
- Heat sterilised injectable compsn of hyaluronic acid or one of the salts thereof, polyols and lidocaine
Anteis 2349203*
- Inhalable particles comprising tiotropium
Laboratoires Liconsa 2349204*
- Chewable gelled emulsions
ProBio 2349205*
- Corticosteroid compsns and methods of treatments thereof
Schering 2349206*
- Liquid pharmaceutical formulation containing paracetamol
Aziende Chinche Riunite Angelini Francesco 2349207*
- Intravaginal delivery system and process for manufacturing it
Bayer 2349208*
- Nanoemulsion therapeutic compounds and methods of using the same
Nanobio 2349209*
- Processes and compsns for liposomal and efficient delivery of gene silencing therapeutics
Marina Biotech 2349210*